The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes

Vesna Dermanovic Dobrota, Pero Hrabac, Dinko Skegro, Ranko Smiljanic, Savko Dobrota, Ingrid Prkacin, Neva Brkljacic, Kristijan Peros, Martina Tomic, Vesna Lukinovic-Skudar, Vanja Basic Kes, Vesna Dermanovic Dobrota, Pero Hrabac, Dinko Skegro, Ranko Smiljanic, Savko Dobrota, Ingrid Prkacin, Neva Brkljacic, Kristijan Peros, Martina Tomic, Vesna Lukinovic-Skudar, Vanja Basic Kes

Abstract

Background: Diabetic polyneuropathy (DPN) is one of the most common complications of diabetes and can exist with or without neuropathic pain. We were interested in how neuropathic pain impairs the quality of life in diabetic patients and what is the role of comorbidities in this condition.

Methods: The study included 80 patients with painful DPN (group "P") and 80 patients with DPN, but without neuropathic pain (group "D"). Visual analogue scale (VAS) and Leeds assessment of neuropathic symptoms and signs (LANSS) pain scale were used for assessment of neuropathic pain, SF-36 standardized questionnaire for assessment of the quality of life and BDI questionnaire for assessment of depression.

Results: Subjects in group P had statistically significantly lower values compared to group D in all 8 dimensions and both summary values of the SF-36 scale. We ascribe the extremely low results of all parameters of SF-36 scale in group P to painful diabetic polyneuropathy with its complications. The patients in group D showed higher average values in all dimension compared to group P, but also somewhat higher quality of life compared to general population of Croatia in 4 of 8 dimensions, namely vitality (VT), social functioning (SF), role-emotional (RE) and mental health (MH), which was unexpected result. Clinically, the most pronounced differences between two groups were noted in sleeping disorders and problems regarding micturition and defecation , which were significantly more expressed in group P. The similar situation was with walking distance and color-doppler sonography of carotid arteries, which were significantly worse in group P. Consequently, subjects in group P were more medicated than the patients in group D, particularly with tramadol, antiepileptics and antidepressants.

Conclusion: Painful DPN is a major factor that influences various aspects of quality of life in diabetic patients. Additionally, this study gives an overview of diabetic population in the Republic of Croatia, information that could prove useful in future studies.

Figures

Figure 1
Figure 1
Mean values of the dimensions of SF-36 scale for the group of diabetic patients with painful neuropathy (black), diabetic patients with painless neuropathy (grey) and random sample of population of Republic of Croatia (white) Physical functioning (PF); Role-physical (RP); Bodily pain (BP); General health (GH); Vitality (VT); Social functioning (SF); Mental Health (MH); Role-emotional (RE).

References

    1. Poljicanin T, Ajduković D, Sekerija M, Pibernik-Okanović M, Metelko Z, Vuletić MG. Diabetes mellitus and hypertension have comparable adverse effects on health-related quality of life. BMC Public Health. 2010;10:12. doi: 10.1186/1471-2458-10-12.
    1. King HH, Aubert RE, Herman WN. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414–1431. doi: 10.2337/diacare.21.9.1414.
    1. Croatian Bureau of Statistics, Census; 2011. [Internet]2013.[ cited 2013. July 30] Avaible from: .
    1. Croatian National Institute of Public Health (HZJZ)- Clinical Hospital Merkur, Vuk Vrhovac University Clinic (KB Merkur, Sveučilišna klinika Vuk Vrhovac) The National Diabetes Registry CroDiab ( Nacionalni registrar osoba sa šećernom bolešću) 2011.
    1. Argoff CE, Cole E, Fishbain DA, Irving GA. Diabetic Peripheral Neuropathic Pain: Clinical and Quality-of-Life Issues. Mayo Clin Proc. 2006;81(4, suppl):S3–S11. doi: 10.1016/S0025-6196(11)61474-2.
    1. Mo F, Pogany LM, Li FCK, Morrison H. Prevalence of Diabetes and Cardiovascular Comorbidity in Canadian Community Health Survey 2002–2003. Sci World J. 2006;24(6):96–105. doi: 10.1100/tsw.2006.13.
    1. Liebl A, Neiss A, Spannheimer A, Reitberger U, Wieseler B, Stammer H, Goertz A. Complications, comorbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany- results from the CODE – 2 study. Exp Clin Endocrinol Diabetes. 2002;110(1):10–16. doi: 10.1055/s-2002-19988.
    1. Mc Carberg B, Billington R. Consequences of Neuropathic Pain: Quality- of-life Issues and Associated Costs. Am J Manag Care. 2006;12:S263–S268.
    1. Koo BK, Ohn JH, Kwak SH, Moon MK. Assessment of diabetic polyneuropathy and autonomic neuropathy using current perception threshold in korean patients with diabetes mellitus. Diabetes Metab J. 2014;38(4):285–293. doi: 10.4093/dmj.2014.38.4.285.
    1. Russell JW, Zilliox LA. Diabetic neuropathies. Continuum (Minneap Minn) 2014. pp. 1226–1240.
    1. Benbow SJ, Wallymahmed ME, Macfarlane IA. Diabetic peripheral neuropathy and quality of life. Q J Med. 1998;91:733–737. doi: 10.1093/qjmed/91.11.733.
    1. Cruccu G, Sommer C, Anand P, Attal N, Baron L, Garcia- Larrea L, Haanpaa M, Jensen TS, Serra J, Treede RD. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010;17(8):1010–1018. doi: 10.1111/j.1468-1331.2010.02969.x.
    1. Bennet MI, Smith BH, Torrance N, Potter J. The S-LANSS Score for Identifying Pain of Predominantly Neuropathic Origin: Validation for Use in Clinical and Postal Research. J Pain. 2005;6(3):149–158. doi: 10.1016/j.jpain.2004.11.007.
    1. Taft C, Karlsson J, Sullivan M. Do SF-36 summary component scores accurately summarize subscale scores? Qual Life Res. 2001;10(5):395–404. doi: 10.1023/A:1012552211996.
    1. Juresa V, Ivanković D, Vuletić G, Babić-Banaszak A, Srcek I, Mastilica M, Budak A. The Croatian Health Survey--SF-36: I. General quality of life assessment. Coll Antropol. 2000;24(1):69–78.
    1. Maslić Sersić D, Vuletić G. Psychometric evaluation and establishing norms of Croatian SF-36 health survey: framework for subjective health research. Croat Med J. 2006;47(1):95–102.
    1. Hintze J: PASS 11. NCSS, LLC. Kaysville, Utah, USA: 2011. .
    1. Schram MT, Baan CA, Pouwer F. Deppession and Quality of Life in Patients with Diabetes: A Systematic Review from the European Depression in Diabetes ( EDID) Research Consortium. Curr Diabetes Rev. 2009;5:112–119. doi: 10.2174/157339909788166828.
    1. Rubin RR. Diabetes and Quality of Life. Diabetes Spectrum. 2000;13:21–25.
    1. Morris NS, Maclean CD, Littenberg B. Change in health literacy over 2 years in older adults with diabetes. Diabetes Educ. 2013;39(5):638–646. doi: 10.1177/0145721713496871.
    1. Sequeira PA, Montoya L, Ruelas V, Xing D, Chen V, Beck R, Peters AL. Continuous glucose monitoring pilot in low-income type 1 diabetes patients. Diabetes Technol Ther. 2013;15(10):855–858. doi: 10.1089/dia.2013.0072.
    1. Park SI. Rural Korean housewives’ attitudes towards illness. Yonsei Med J. 1987;28(2):105–111. doi: 10.3349/ymj.1987.28.2.105.
    1. Engel J, Pedley TA. Epilepsy: A Comprehensive Textbook. 2. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 2181.
    1. Ntozi JP, Kirunga CT. HIV/AIDS, change in sexual behaviour and community attitudes in Uganda. Health Transit Rev. 1997;7(Suppl):157–174.
    1. Broomhead T, Baker SR, Jones K, Richardson A, Marshman Z. What are the most accurate predictors of caries in children aged 5 years in the UK? Community Dent Health. 2014;31(2):111–116.
    1. Brown CJ, Flood KL. Mobility limitation in the older patient: a clinical review. JAMA. 2013;310(11):1168–1177. doi: 10.1001/jama.2013.276566.
    1. Novak P, Burger H, Marincek C, Meh D. Influence of foot pain on walking ability of diabetic patients. J Rehabil Med. 2004;36:249–252. doi: 10.1080/16501970410029816.
    1. Cade WT. Diabetes– Related Microvascular and Macrovascular Diabetes in the Physical Therapy Setting. Phys Ther. 2008;88(11):1322–1335. doi: 10.2522/ptj.20080008.
    1. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, Pittrow D, von Stritzky B, Tepohl G, Trampisch HJ. High prevalence of periferal arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis. 2004;172(1):95–105. doi: 10.1016/S0021-9150(03)00204-1.
    1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta analysis. Diabetes Care. 2001;24(6):1069–1078. doi: 10.2337/diacare.24.6.1069.
    1. Moreira RO, Amancio AP, Brum HR, Vasconcelos DL, Nascimento GF. Depressive symptoms and quality of life in type 2 diabetic patients with diabetic distal polyneuropathy. Arq Bras Endocrinol Metabol. 2009;53(9):1103–1111. doi: 10.1590/S0004-27302009000900007.
    1. Mc Collum M, Ellis SL, Regensteiner JG, Zhang W, Sullivan PW. Minor depression and Health status among US adults with diabetes mellitus. Am J Manag Care. 2007;13(2):65–72.
    1. Cocito D, Paolasso I, Pazzaglia C, Tavella A, Poglio E, Ciaramitaro P, Scarmozzino A, Cossa FM, Bergamasco B, Padua L. Pain affects the quality of life of neuropathic patients. Neurol Sci. 2006;27:155–160. doi: 10.1007/s10072-006-0660-5.
    1. Piette JD, Kerr EA. The impact of Comorbid Cronic Conditions on Diabetes Care. Diabetes Care. 2006;29(3):725–731. doi: 10.2337/diacare.29.03.06.dc05-2078.
    1. Ventegodt S, Kandel I, Merrick J. Quality of life and philosophy of life determines physical and mental health: status over research findings from the Quality of Life Research Center, Copenhagen, 1991–2007. ScientificWorldJournal. 2007;7:1743–1751. doi: 10.1100/tsw.2007.261.
    1. Davidson MH. Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist. Am J Cardiol. 2012;110(9 Suppl):43B. doi: 10.1016/j.amjcard.2012.08.033.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner